The acquisition of Senn Chemicals enhances Granules India’s capabilities in peptide therapeutics, targeting anti-diabetic, anti-obesity, and next-generation APIs Granules India (BSE: 532482, NSE: GRANULES) has signed an agreement to acquire Senn Chemicals AG, a Swiss-based Contract Development and Manufacturing Organization (CDMO) specializing in peptide synthesis. This strategic acquisition will accelerate Granules’ entry into the high-growth … Continue reading Swiss CDMO Senn Chemicals Acquired to Fuel Granules India’s Peptide Drug Development